首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.
【24h】

Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.

机译:口腔鳞状细胞癌中动态细胞内生存素的潜在分子机制和作为早期预后标志物的潜力。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Survivin functions as an apoptosis inhibitor and a regulator of cell division in many tumours. The intracellular localization of survivin in tumours has been suggested as a prognostic marker. However, current reports are inconsistent and the underlying molecular mechanisms are not understood. The present study has examined the localization and prognostic value of nuclear and cytoplasmic survivin in the pre-therapeutic biopsies from 71 oral and oropharyngeal squamous carcinoma (OSCC) patients. Statistical analysis indicated that preferential nuclear versus cytoplasmic survivin correlated with favourable versus unfavourable disease outcome. Uni- and multi-variate analysis showed that in contrast to total survivin expression, the difference between nuclear and cytoplasmic survivin was a strong predictor for relapse-free survival (p=0.0003). As a potential underlying molecular mechanism, it is shown in OSCC cell lines that predominantly cytoplasmic survivin mediates protection against chemo- and radio-therapy-induced apoptosis. Importantly, the cytoplasmic localization of survivin is regulated by its nuclear export signal (NES), and export-deficient nuclear survivin is not cytoprotective. This study suggests that the difference between cytoplasmic and nuclear survivin is an indicator for survivin activity in tumour cells. Thus, this difference may serve as a predictive marker of outcome in OSCC patients undergoing multi-modality therapy. The pharmacogenetic interference with survivin's cytoplasmic localization is also to be pursued as a potential therapeutic strategy. Published by John Wiley & Sons, Ltd.
机译:Survivin在许多肿瘤中起凋亡抑制剂和细胞分裂调节剂的作用。 Survivin在肿瘤中的细胞内定位已被认为是一种预后指标。但是,目前的报道不一致,潜在的分子机制尚不清楚。本研究检查了71名口腔和口咽鳞癌(OSCC)患者的治疗前活检中核和细胞质survivin的定位和预后价值。统计分析表明,优先的核相对于细胞质的survivin与疾病的有利与不利相关。单变量和多变量分析表明,与总生存素表达相反,核和细胞质生存素之间的差异是无复发生存的重要预测因子(p = 0.0003)。作为潜在的潜在分子机制,在OSCC细胞系中显示,主要是细胞质survivin介导了针对化学疗法和放射疗法诱导的细胞凋亡的保护作用。重要的是,survivin的胞质定位受其核输出信号(NES)的调节,而缺乏出口的核survivin则没有细胞保护作用。这项研究表明,细胞质和核survivin之间的差异是肿瘤细胞中survivin活性的指标。因此,这种差异可以作为接受多模式治疗的OSCC患者预后的预测指标。对survivin胞质定位的药物遗传学干扰也应作为一种潜在的治疗策略进行。由John Wiley&Sons,Ltd.出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号